CVE-2023-21921Vulnerability in the Oracle Health Sciences InForm product of Oracle Health Sciences Applications (component: Core).
Updated under an hour ago ()
Does this affect you?
It affects Oracle Corporation Health Sciences InForm. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Vulnerability in the Oracle Health Sciences InForm product of Oracle Health Sciences Applications (component: Core). Supported versions that are affected are Prior to 6.3.1.3 and Prior to 7.0.0.1. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Health Sciences InForm. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Health Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Health Sciences InForm accessible data. CVSS 3.1 Base Score 5.4 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N).
- CVSS
- 5.4 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N
- Weakness (CWE)
- Not given
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- oracle
- NVD analysis
- Modified
- Record last updated
- Sep 16, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
Oracle Corporation Health Sciences InForm oracle:health_sciences_inform (from the name) | before 6.3.1.3; before 7.0.0.1 | CNA record |
oracle health_sciences_inform oracle:health_sciences_inform | before 6.3.1.3; 7.0.0.0 | NVD |
References
- https://www.oracle.com/security-alerts/cpuapr2023.htmlvendor-advisory, patch
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.